The forecast data for the share of corresponding/leading authors in scientific publications in pharmacy in China indicates a slight decline from 2024 to 2028. The values marginally decrease from 98.44% in 2024 to 98.39% in 2028. Without specific 2023 data, the starting reference point remains unclear. However, the trend suggests a very gradual reduction, highlighting consistency but a potential trend of decentralization or diversification in authorship roles.

Future trends to watch for:

Increased collaboration across international borders might influence these dynamics further.
Technological advancements aiding decentralized research could shift leading contributions, diversifying the authorship landscape.
Policy changes within China's academic and research sectors may also impact these figures through more equitable author distribution.